Moderate to Severe Opioid Use Disorder
3 clinical trials · Condition
◉ Watch Moderate to Severe Opioid Use Disorder
| Record | Firm | Date |
|---|---|---|
| Buprenorphine Extended-Release Subcutaneous Injection (RBP-6000) in High-risk Users (NCT04995029) | Indivior Inc. | 2021-10-26 |
Track Moderate to Severe Opioid Use Disorder automatically
Every clearance here is in the API, with alerts when new ones post.